Fifty years of research on cannabidiol (CBD) as an anticonvulsant: The legacy of Brazilian groups.
作者信息
Zuardi Antonio Waldo, Crippa José Alexandre
机构信息
Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil. Medicina Translacional, Instituto Nacional de Ciência e Tecnologia (INCT), Ribeirão Preto, SP, Brazil.
出版信息
Braz J Psychiatry. 2023 Nov-Dec;45(6):463-464. doi: 10.47626/1516-4446-2023-3377. Epub 2023 Nov 25.
Abstract
摘要
相似文献
1
Fifty years of research on cannabidiol (CBD) as an anticonvulsant: The legacy of Brazilian groups.
Braz J Psychiatry. 2023 Nov-Dec;45(6):463-464. doi: 10.47626/1516-4446-2023-3377. Epub 2023 Nov 25.
2
The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.大麻二酚在难治性癫痫治疗中的效用。
Clin Pharmacol Ther. 2017 Feb;101(2):182-184. doi: 10.1002/cpt.441. Epub 2016 Sep 29.
3
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.大麻二酚治疗难治性癫痫和癫痫发作障碍。
Adv Exp Med Biol. 2021;1264:93-110. doi: 10.1007/978-3-030-57369-0_7.
4
Cannabidiol as potential treatment in refractory pediatric epilepsy.大麻二酚作为难治性小儿癫痫的潜在治疗方法。
Expert Rev Neurother. 2016;16(1):17-21. doi: 10.1586/14737175.2016.1121098. Epub 2015 Dec 9.
5
Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.评估血清素能受体在大麻二酚抗惊厥疗效中的作用。
Epilepsy Behav. 2017 Aug;73:111-118. doi: 10.1016/j.yebeh.2017.04.045. Epub 2017 Jun 16.
6
The case for assessing cannabidiol in epilepsy.评估大麻二酚治疗癫痫的作用。
Epilepsia. 2014 Jun;55(6):787-90. doi: 10.1111/epi.12635. Epub 2014 May 22.
7
Cannabidiol and epilepsy: Rationale and therapeutic potential.大麻二酚与癫痫：原理及治疗潜力。
Pharmacol Res. 2016 May;107:85-92. doi: 10.1016/j.phrs.2016.03.005. Epub 2016 Mar 11.
8
Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.大麻二酚在癫痫中的生化作用及治疗机制。
Neurosci Biobehav Rev. 2022 Jan;132:1214-1228. doi: 10.1016/j.neubiorev.2020.09.027. Epub 2020 Oct 5.
9
Cannabidiol and epilepsy in Brazil: a current review.大麻二酚与巴西的癫痫：当前综述。
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):182-192. doi: 10.1590/0004-282X-ANP-2022-S137.
10
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.大麻二酚在体外和体内均显示出抗癫痫和抗惊厥特性。
J Pharmacol Exp Ther. 2010 Feb;332(2):569-77. doi: 10.1124/jpet.109.159145. Epub 2009 Nov 11.
本文引用的文献
1
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.Lennox-Gastaut 综合征相关癫痫患儿中使用大麻二酚治疗的随机、双盲、安慰剂对照 3 期临床试验（GWPCARE4）
Lancet. 2018 Mar 17;391(10125):1085-1096. doi: 10.1016/S0140-6736(18)30136-3. Epub 2018 Jan 26.
2
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.Dravet 综合征患者应用大麻二酚治疗耐药性癫痫发作的试验
N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.
3
Chronic administration of cannabidiol to healthy volunteers and epileptic patients.对健康志愿者和癫痫患者长期给予大麻二酚。
Pharmacology. 1980;21(3):175-85. doi: 10.1159/000137430.
4
Effect of cannabidiol and of other cannabis sativa compounds on hippocampal seizure discharges.大麻二酚及其他大麻化合物对海马癫痫放电的影响。
Psychopharmacologia. 1973;28(1):95-102. doi: 10.1007/BF00413961.
5
Letter: Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents.
J Pharm Pharmacol. 1973 Aug;25(8):664-5. doi: 10.1111/j.2042-7158.1973.tb10660.x.
Zotero 插件